-Patchoulene (-PAE) inhibits the progression of non-alcoholic fatty liver disease (NAFLD) by activating AMPK, which suppresses hepatic lipid synthesis and promotes mitochondrial fatty acid oxidation
31,32 This can lead to the activation of microglia and induce changes in white matter, subsequently causing loss of oligodendrocytes, oligodendrocyte precursor cells, and myelin
Access this article Similar content being viewed by others References Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance Reilly JJ, Kelly J
Feimeng Zhou (University of Jinan)
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes
Mindful eating strategies help patients reconnect with internal hunger cues